Cafepharma Today

April 15 2025 - GSK in breach for misleading prescription information on Omjjara
GSK in breach for misleading prescription information on Omjjara
Bristol Myers stumbles in bid to widen heart drug’s use
Johnson & Johnson Q1 2025 slides reveal strong growth across diversified portfolio
After delays, first vaccine advisory meeting under RFK Jr. set to start
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dendreon At The Mercy Of Provenge
Forbes
Friday, November 7, 2008 - 12:33pm
tags:
"Boning Up" On Amgen's D-mab
CNBC
Friday, November 7, 2008 - 12:32pm
tags:
Nektar Therapeutics' 3rd-quarter loss widens on continued revenue drop
Yahoo/AP
Friday, November 7, 2008 - 12:31pm
tags:
WuXi Pharma announces three-year deal with Pfizer
Yahoo/AP
Friday, November 7, 2008 - 12:30pm
tags:
FDA Panelist Sid Wolfe: ‘I Hope To Have Influence’
Pharmalot
Friday, November 7, 2008 - 10:26am
tags:
Who will take over at the FDA, HHS?
Fierce Pharma
Friday, November 7, 2008 - 10:25am
tags:
Tiggergate: Using Disney Icons To Sell Seroquel
Pharmalot
Friday, November 7, 2008 - 10:24am
tags:
Biovail on prowl for acquisition
Globe and Mail, Canada
Friday, November 7, 2008 - 10:21am
tags:
Amgen’s CEO Predicts His Crisis Will Soon End
Pharmalot
Friday, November 7, 2008 - 10:20am
tags:
Senate Power Brokers Moving on Health Reform
WSJ Online
Friday, November 7, 2008 - 10:16am
tags:
Isis Technology Used to Attack Brain Tumors
Seeking Alpha
Friday, November 7, 2008 - 10:14am
tags:
Investors Liked What They Saw in Simcere's Q3 Report
Seeking Alpha
Friday, November 7, 2008 - 10:13am
tags:
Icagen posts loss on 75% revenue drop
Bizjournals.com
Friday, November 7, 2008 - 10:12am
tags:
Sanofi-Aventis cut to sell at UBS
Marketwatch
Friday, November 7, 2008 - 9:59am
tags:
PowerRatings Best of the Requests: GS, PFE, JNJ
Yahoo/Trading Markets
Friday, November 7, 2008 - 9:57am
tags:
Amgen to Review Business with Analysts
The Street.com
Friday, November 7, 2008 - 9:55am
tags:
Wyeth's Day In Court (WYE)
Investopedia
Friday, November 7, 2008 - 9:54am
tags:
Express Scripts, FBI, Probe Threat to Expose Records
Bloomberg
Friday, November 7, 2008 - 9:52am
tags:
Daiichi Sankyo Completes Purchase of 63.9% of Ranbaxy
Bloomberg
Friday, November 7, 2008 - 9:47am
tags:
Big Pharma’s Loss May Be Little Pharma’s Gain
Pharmalot
Thursday, November 6, 2008 - 9:52am
tags:

Pages

Latest CP Wire Articles

The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform

Latest Pharmagather Articles

RNA Motifs Coming Into Focus
In the Pipeline
Pharmaceutical Tariffs: The What and the How
In the Pipeline
Metallic Flatland
In the Pipeline
The Continuing Crisis, Part XI: Feral Children, Breaking Things
In the Pipeline
Methyl Groups Will Always Be Magic
In the Pipeline
Predicting Picky Protein Interactions
In the Pipeline
The Continuing Crisis, Part X: Reductions in Force, Gains in Centralized Power
In the Pipeline
A New Pan-Coronovirus Protease Inhibitor Possibility
In the Pipeline
Pain Continues to Be a Pain
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.